Opinercept

依那西普生物类似药 (Mycenax Biotech/TSH Biopharm)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameOpinercept
Drug Alias Name依那西普生物仿制药 (Mycenax Biotech/TSH Biopharm)TuNEX TNFαR-FcEtanercept biosimilar (Mycenax Biotech/TSH Biopharm)TuNEXE-11 +[6] 
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion proteinBiologics > Biosimilar
Mechanisms of ActionTumor necrosis factor β inhibitorsTumor necrosis factor α inhibitors
TargetsTumor necrosis factor βTumor necrosis factor α
Therapy Area/IndicationsArthritis, RheumatoidSpondylitis, Ankylosing
Global Approved IndicationsArthritis, Rheumatoid
Approved Indications in ChinaN/A
Original Approved Country/TerritoryTaiwan
Original Approved Date2017/01/01
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesTSH Biopharm Corp LtdMycenax Biotech Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTSH Biopharm Corp LtdMycenax Biotech Inc
Active IndicationsArthritis, Rheumatoid
Inactive IndicationsSpondylitis, Ankylosing

Other Information

ATC CodeL04AB01
Related LinksN/A